P01-010 – Anti-TNF Agents in Intractable FMF: Four Cases

Pediatric Rheumatology - United Kingdom
doi 10.1186/1546-0096-11-s1-a14
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

P01-032 – Characterization of Genetic-Negative FMF

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

P01-031 – Anakinra for Colchicine Resistant FMF

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

P01-027 – Normal HRV in Colchicine-Resistant FMF Patients

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2013English

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients With Rheumatoid Arthritis

Genes
Genetics
2018English

Editorial: Therapeutic Drug Monitoring for Anti-TNF Agents-Has It All Been Said? Author's Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Combination of Active and Passive Anti-TNF Treatments in Human-TNF Transgenic Mice

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2011English

P038 in Vivo Demonstration of tmTNF Reverse Signaling: Significance in the Therapeutic Response to Anti-TNF Agents During Murine Arthritis

2019English

Four Cases of Hematomyelia.

Spinal Surgery
1988English

FRI0221 Does Seropositivity Influence Differentially Drug Discontinuation of Biologic Antirheumatic Agents With Non-Anti-TNF Mode of Action?

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy